Msefsl

CLOSE X

Risk Disclosures on Derivatives

>9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
>On an average, loss makers registered net trading loss close to ₹ 50,000.
>Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
>Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.

NGL FINE-CHEM LTD.

NSE : NGLFINEBSE : 524774ISIN CODE : INE887E01022Industry : Pharmaceuticals & DrugsHouse : Private

BSE1334.9055.55 (+4.34 %)

PREV CLOSE ( ) 1279.35

OPEN PRICE ( ) 1288.30

BID PRICE (QTY) 1321.55 (7)

OFFER PRICE (QTY) 1334.90 (5)

VOLUME 92

TODAY'S LOW / HIGH ( )1288.30 1347.80

52 WK LOW / HIGH ( )962.7 2161

NSE1325.0046.2 (+3.61 %)

PREV CLOSE( ) 1278.80

OPEN PRICE ( ) 1278.00

BID PRICE (QTY) 1325.00 (34)

OFFER PRICE (QTY) 1330.20 (1)

VOLUME 3007

TODAY'S LOW / HIGH( ) 1272.80 1350.30

52 WK LOW / HIGH ( )957 2077.45

BSE NSE

1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 1981

Management Info

Dhananjay Mungale - Chairman Rahul Nachane - Managing Director

Registered Office

Address 301 E Square,Subhash Road,Vile Parle (East),
Mumbai,
Maharashtra-400057

Phone 022 26636450

Email info@nglfinechem.com

Website www.nglfinechem.com

Registrars Details

Purva Shareregistry (India) Pvt Ltd

Gala No 9,Shiv Shakti, Industrial Estate,Sitaram Mill Comp.,J R Boricha Marg, Lower Parel [E],Mumbai

Listing : BSE, NSE

NEWS

25Jul NGL Fine-Chem submits BRSR
Pursuant to Regulation 34(2)(f) of the Securities and Exchange Board of..

10Jul NGL Fine Chem informs about compliance
NGL Fine Chem has informed that it enclosed compliance certificate under..

27Jun NGL Fine-Chem informs about credit rat
Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Re..

19Apr NGL Fine Chem informs about disclosure
NGL Fine Chem has informed that NGL Fine-Chem is not falling under the c..

06Mar NGL Fine-Chem informs about outcome of
NGL Fine-Chem has informed that the fourth Meeting of the Board of Direc..

Financials

Rs. in Millions

	QTR Sep 25	ANNUAL 25
Net Profit	78.98	181.32
Gross Profit	106.57	238.82
Operating Profit	160.75	354.59
Net Sales	1168.39	3592.94

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Fredun Pharma (BSE) 1741.00 (6.76%)	M.Cap ( in Cr)832.95
Ajanta Pharma (BSE) 2709.25 (3.31%)	M.Cap ( in Cr)33739.49
Alkem Laboratories (BSE) 5645.10 (1.50%)	M.Cap ( in Cr)67506.40
Sanofi India (BSE) 4125.00 (1.40%)	M.Cap ( in Cr)9482.28
Glenmark Pharma (BSE) 2034.95 (2.22%)	M.Cap ( in Cr)57574.61

Shareholding Pattern

	PROMOTERS	72.74%
	NON-INSTITUTION	27.26%
	MUTUAL FUNDS/UTI	0%
	FI/BANKS/INSURANCE	0%
	GOVERNMENT	0%
	FII	0%

Mf Holdings

Scheme Name	Hold(%)
Bandhan BSE Healthc...	0.01
Motilal Oswal BSE H...	0.01

Risk Disclosures on Derivatives

Smart Quotes

NGL FINE-CHEM LTD.